Jump to content

Joseph Yanai: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Fix cite date error
m →Research work: Grammar
 
(17 intermediate revisions by 10 users not shown)
Line 1: Line 1:
{{Short description|Israeli scientist and researcher}}
{{Short description|Israeli scientist and researcher}}
{{distinguish|Joseph Yaani Labik}}
{{distinguish|Joseph Yaani Labik}}
{{Infobox scientist
[[File:Joseph Yanai Portrait.png|thumb]]
| name = Joseph Yanai
⚫
'''Joseph Yanai''' is a researcher pioneering in studying the reversal of neurobehavioral [[birth defect]]s in animal models.<ref>{{Cite journal |last=Yanai |first=Joseph |last2=Vigoda |first2=Myles J. |last3=Ornoy |first3=Asher |date=August 2019 |title=Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress |url=http://dx.doi.org/10.1016/j.brainresbull.2019.06.009 |journal=Brain Research Bulletin |volume=150 |pages=328–342 |doi=10.1016/j.brainresbull.2019.06.009 |issn=0361-9230}}</ref> He serves as a professor and Director of the Ross Laboratory for Studies in Neural Birth Defects at the Department of Medical Neurobiology, The [[Institute For Medical Research, Israel-Canada]] (IMRIC) at the Hebrew University-Hadassah Medical School Jerusalem, Israel and was also appointed as Adjunct Professor, Department of [[Pharmacology]] and Cancer Biology, [[Duke University School of Medicine]], Durham, NC, USA.
| birth_date = 1944
| birth_place = Rehovot, Israel
| nationality = Israeli
| fields = Neurobiology, Pharmacology
| workplaces = Hebrew University of Jerusalem, Duke University School of Medicine
| alma_mater = Hebrew University of Jerusalem, University of Colorado Boulder
| known_for = Reversal of neurobehavioral birth defects in animal models
| title = Professor and Director of the Ross Laboratory for Studies in Neural Birth Defects
| awards =
| notable_works = Studies on neurobehavioral teratology
| image =
| image_size =
| image_caption =
}}
⚫
'''Joseph Yanai''' is a researcher pioneering in studying the reversal of neurobehavioral [[birth defect]]s in animal models.<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Vigoda |first2=Myles J. |last3=Ornoy |first3=Asher |date=August 2019 |title=Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress |url=http://dx.doi.org/10.1016/j.brainresbull.2019.06.009 |journal=Brain Research Bulletin |volume=150 |pages=328–342 |doi=10.1016/j.brainresbull.2019.06.009 |pmid=31207281 |s2cid=189820103 |issn=0361-9230}}</ref> He serves as a professor and Director of the Ross Laboratory for Studies in Neural Birth Defects at the Department of Medical Neurobiology, The [[Institute For Medical Research, Israel-Canada]] (IMRIC) at the Hebrew University-Hadassah Medical School Jerusalem, Israel and was also appointed as adjunct professor, Department of [[Pharmacology]] and Cancer Biology, [[Duke University School of Medicine]], Durham, NC, US.


== Education ==
== Education ==
Line 9: Line 24:
== Professional career ==
== Professional career ==
* Professor, Department of Medical Neurobiology, [[Hebrew University]], [[Hadassah Medical School]], Jerusalem, since 1978.
* Professor, Department of Medical Neurobiology, [[Hebrew University]], [[Hadassah Medical School]], Jerusalem, since 1978.
* Adjunct professor, Department of Pharmacology and Cancer Biology, [[Duke University School of Medicine]], Durham, North Carolina, 1991-2020.<ref>{{Cite web|url=https://medicine.ekmd.huji.ac.il/en/research/josephy/Pages/default.aspx|title=Professor Joseph Yanai|website=The Hebrew University of Jerusalem}}</ref>
* [[Adjunct professor]], Department of Pharmacology and Cancer Biology, [[Duke University School of Medicine]], Durham, North Carolina, 1991-2020.<ref>{{Cite web|url=https://medicine.ekmd.huji.ac.il/en/research/josephy/Pages/default.aspx|title=Professor Joseph Yanai|website=The Hebrew University of Jerusalem}}</ref>
* Director, Ross Laboratory for Studies in Neural Birth Defects, Department of Neurobiology, Hebrew University Hadassah Medical School, Jerusalem, since 1987.
* Director, Ross Laboratory for Studies in Neural Birth Defects, Department of Neurobiology, Hebrew University Hadassah Medical School, Jerusalem, since 1987.


== Research work ==
== Research work ==
Since 1973, he has been among the pioneers in the study of behavioral birth defects. Yanai has studied the mechanism by which certain neuroteratogens induce their deleterious effect, focusing on behavioral defects that are mechanistically related to the septohippocampal cholinergic innervation. The results showed alterations in cholinergic neurotransmission cascade into the abolishment of the cholinergic receptor-induced activation/translocation PKC activity. By ascertaining the mechanisms of the neuroteratogenicity, he pointed to the future of the field by establishing the concept of “neurobehavioral teratology.”
Since 1973, he has been among the forerunners in the study of behavioral birth defects.<ref>{{Cite journal |date=December 1973 |title=Behavior genetics association abstracts |url=http://dx.doi.org/10.1007/bf01070223 |journal=Behavior Genetics |volume=3 |issue=4 |pages=393–419 |doi=10.1007/bf01070223 |s2cid=189854750 |issn=0001-8244}}</ref> His novel approach was to study the mechanism by which certain neuroteratogens induce their deleterious effect, focusing on behavioral defects that are mechanistically related to septohippocampal cholinergic innervation.<ref>{{Cite journal |date=December 1973 |title=Behavior genetics association abstracts |url=http://dx.doi.org/10.1007/bf01070223 |journal=Behavior Genetics |volume=3 |issue=4 |pages=393–419 |doi=10.1007/bf01070223 |s2cid=189854750 |issn=0001-8244}}</ref> The results showed alterations in cholinergic neurotransmission cascade converging into the abolishment of the cholinergic receptor-induced activation/translocation PKC activity.<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Beer |first2=Avital |last3=Huleihel |first3=Rabab |last4=Izrael |first4=Michal |last5=Katz |first5=Sofia |last6=Levi |first6=Yaarit |last7=Rozenboim |first7=Israel |last8=Yaniv |first8=Shiri P. |last9=Slotkin |first9=Theodore A. |date=October 2004 |title=Convergent Effects on Cell Signaling Mechanisms Mediate the Actions of Different Neurobehavioral Teratogens: Alterations in Cholinergic Regulation of Protein Kinase C in Chick and Avian Models |url=http://dx.doi.org/10.1196/annals.1316.074 |journal=Annals of the New York Academy of Sciences |volume=1025 |issue=1 |pages=595–601 |doi=10.1196/annals.1316.074 |pmid=15542768 |s2cid=10927050 |issn=0077-8923}}</ref> By ascertaining the mechanisms of the neuroteratogenicity, he pointed in his book “neurobehavioral teratology.”
<ref>{{Cite book |url=https://www.worldcat.org/oclc/10275574 |title=Neurobehavioral teratology |date=1984 |publisher=Elsevier |others=Joseph Yanai |isbn=0-444-80516-8 |location=Amsterdam |oclc=10275574}}</ref> Since 1987, Yanai has developed animal models for the reversal of neurobehavioral birth defects, starting with manipulation of A10 septal dopaminergic innervation, nicotine therapy, but most significantly, by transplantation of cells to the impaired brain. These included fetal differentiated brain cells and, in subsequent studies, stem cells of various origins: embryonic, neural stem cells, subventricular stem cells, and mesenchymal stem cells.<ref>{{cite web |title=Stem cell therapy may reverse brain birth defects |url=https://www.oneindia.com/2008/12/30/stem-cell-therapy-may-reverse-brain-birth-defects.html |website=Oneindia.com |language=en |date=30 December 2008}}</ref>
<ref>{{Cite book |title=Neurobehavioral teratology |date=1984 |publisher=Elsevier |editor=Joseph Yanai |isbn=0-444-80516-8 |location=Amsterdam |oclc=10275574}}</ref> to the future of the field by establishing the concept of "Neurobehavioral teratology. Furthermore, Yanai argued that understanding the mechanism of the developmental defect will eventually enable its reversal, a concept that seemed like science fiction in 1984.
⚫
Transplantation of cells of all types reversed the prenatally-induced behavioral deficits and the mechanistically related neural alterations. He has established the principle that the induction of neurogenesis is one of the major mechanisms by which stem cells exert their therapeutic effect.<ref>{{cite web |title=Health Scan: Stem cell therapy may reverse brain defects |url=https://www.jpost.com/health-and-sci-tech/health/health-scan-stem-cell-therapy-may-reverse-brain-defects |website=The Jerusalem Post}}</ref><ref>{{Cite journal |last=Ben-Shaanan |first=T L |last2=Ben-Hur |first2=T |last3=Yanai |first3=J |date=2007-09-18 |title=Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain |url=http://dx.doi.org/10.1038/sj.mp.4002084 |journal=Molecular Psychiatry |volume=13 |issue=2 |pages=222–231 |doi=10.1038/sj.mp.4002084 |issn=1359-4184}}</ref>


Specifically since 1987, Yanai has developed animal models for the reversal of neurobehavioral birth defects, starting with manipulation of A10 septal dopaminergic innervation,<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Laxer |first2=Uri |last3=Pick |first3=Chaim G. |last4=Trombka |first4=David |date=August 1989 |title=Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital |url=http://dx.doi.org/10.1016/0165-3806(89)90080-1 |journal=Developmental Brain Research |volume=48 |issue=2 |pages=255–261 |doi=10.1016/0165-3806(89)90080-1 |pmid=2505945 |issn=0165-3806}}</ref> nicotine therapy,<ref>{{Cite journal |last1=Beer |first1=Avital |last2=Slotkin |first2=Theodore A |last3=Seidler |first3=Frederic J |last4=Aldridge |first4=Justin E |last5=Yanai |first5=Joseph |date=2004-10-20 |title=Nicotine Therapy in Adulthood Reverses the Synaptic and Behavioral Deficits Elicited by Prenatal Exposure to Phenobarbital |journal=Neuropsychopharmacology |volume=30 |issue=1 |pages=156–165 |doi=10.1038/sj.npp.1300582 |pmid=15496940 |issn=0893-133X|doi-access=free }}</ref> but most significantly, by transplantation of cells to the impaired brain. These included fetal differentiated brain cells (neural grafting),<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Pick |first2=Chaim G. |date=1988 |title=Neuron transplantation reverses phenobarbital-induced behavioral birth defects in mice |url=http://dx.doi.org/10.1016/0736-5748(88)90046-9 |journal=International Journal of Developmental Neuroscience |volume=6 |issue=5 |pages=409–416 |doi=10.1016/0736-5748(88)90046-9 |pmid=3202000 |s2cid=23370083 |issn=0736-5748}}</ref> and in subsequent studies, stem cells of various origins: embryonic, neural stem cells,<ref>{{Cite journal |last1=Kazma |first1=Meital |last2=Izrael |first2=Michal |last3=Revel |first3=Michel |last4=Chebath |first4=Judith |last5=Yanai |first5=Joseph |date=2010-02-01 |title=Survival, differentiation, and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural stem cells derived from embryonic stem cells |url=http://dx.doi.org/10.1002/jnr.22193 |journal=Journal of Neuroscience Research |volume=88 |issue=2 |pages=315–323 |doi=10.1002/jnr.22193 |pmid=19746435 |s2cid=24682086 |issn=0360-4012}}</ref> subventricular stem cells,<ref>{{Cite journal |last1=Turgeman |first1=Gadi |last2=Pinkas |first2=Adi |last3=Slotkin |first3=Theodore A. |last4=Tfilin |first4=Matanel |last5=Langford |first5=Rachel |last6=Yanai |first6=Joseph |date=2011-04-21 |title=Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by allographic transplantation of adult subventricular zone-derived neural stem cells |url=http://dx.doi.org/10.1002/jnr.22631 |journal=Journal of Neuroscience Research |volume=89 |issue=8 |pages=1185–1193 |doi=10.1002/jnr.22631 |pmid=21520219 |s2cid=3424029 |issn=0360-4012}}</ref> and mesenchymal stem cells.<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Vigoda |first2=Myles J. |last3=Ornoy |first3=Asher |date=August 2019 |title=Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress |url=http://dx.doi.org/10.1016/j.brainresbull.2019.06.009 |journal=Brain Research Bulletin |volume=150 |pages=328–342 |doi=10.1016/j.brainresbull.2019.06.009 |pmid=31207281 |s2cid=189820103 |issn=0361-9230}}</ref><ref>{{cite web |title=Stem cell therapy may reverse brain birth defects |url=https://www.oneindia.com/2008/12/30/stem-cell-therapy-may-reverse-brain-birth-defects.html |website=Oneindia.com |language=en |date=30 December 2008}}</ref>
⚫
Yanai developed a method to replace defective cells in the brains of mice whose mothers were given heroin during pregnancy. They injected embryonic neural [[stem cell]]s directly into the brains of the affected mice. These cells migrate in the brain, search for the deficiency that caused the defect, and then differentiate into becoming the cells needed to repair the damage. Their findings were published in the leading journal, ''[[Molecular Psychiatry]]'',<ref>{{cite web |title=Israeli scientists reverse brain birth defects using stem cells |url=https://www.israel21c.org/israeli-scientists-reverse-brain-birth-defects-using-stem-cells/ |website=ISRAEL21c |access-date=28 March 2022 |date=25 December 2008}}</ref><ref>Ben-Shaanan, TL, Ben-Hur, T, and Yanai, J.: “Transplantation of neural progenitors enhances production of endogeneous cells in the impaired brain”. Molecular Psychiatry, September 18, 2007. Vol. 13, No. 2, pp222-231</ref> and presented<ref>{{cite web |title=Hebrew University Scientists Succeed Through Stem Cell Therapy in Reversing Brain Birth Defects |url=https://www.technologynetworks.com/cell-science/news/hebrew-university-scientists-succeed-through-stem-cell-therapy-in-reversing-brain-birth-defects-196809 |website=Technology Networks |language=en}}</ref><ref>{{cite web |title=Stem Cells Undo Birth Defects |url=https://www.technologyreview.com/2009/01/07/216614/stem-cells-undo-birth-defects/ |website=MIT Technology Review |language=en}}</ref> at international conferences in [[San Antonio, Texas]], in June 2016<ref>Fortieth Anniversary Annual Meeting of the Developmental Neurotoxicology Society Held in Conjunction with the 56th Annual Meeting of the Teratology Society Grand Hyatt San Antonio, San Antonio, Texas June 25, 2016 10:15-11AM</ref> and in Basel, Switzerland in February 2017.
⚫
Transplantation of cells of all types reversed the prenatally-induced behavioral deficits and the mechanistically related neural alterations. Further studies suggested that one major mechanism by which the stem cells exert their therapeutic action is by enhancing neurogenesis.<ref>{{cite web |title=Health Scan: Stem cell therapy may reverse brain defects |url=https://www.jpost.com/health-and-sci-tech/health/health-scan-stem-cell-therapy-may-reverse-brain-defects |website=The Jerusalem Post}}</ref><ref>{{Cite journal |last1=Ben-Shaanan |first1=T L |last2=Ben-Hur |first2=T |last3=Yanai |first3=J |date=2007-09-18 |title=Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain |journal=Molecular Psychiatry |volume=13 |issue=2 |pages=222–231 |doi=10.1038/sj.mp.4002084 |pmid=17876325 |s2cid=12784221 |issn=1359-4184|doi-access=free }}</ref>


⚫
These findings were published in the leading journal (for example ''[[Molecular Psychiatry]]'',<ref>Ben-Shaanan, TL, Ben-Hur, T, and Yanai, J.: “Transplantation of neural progenitors enhances production of endogeneous cells in the impaired brain”. Molecular Psychiatry, September 18, 2007. Vol. 13, No. 2, pp222-231</ref>) and received a widespread media attention (external links<ref>{{cite web |title=Hebrew University Scientists Succeed Through Stem Cell Therapy in Reversing Brain Birth Defects |url=https://www.technologynetworks.com/cell-science/news/hebrew-university-scientists-succeed-through-stem-cell-therapy-in-reversing-brain-birth-defects-196809 |website=Technology Networks |language=en}}</ref><ref>{{cite web |title=Stem Cells Undo Birth Defects |url=https://www.technologyreview.com/2009/01/07/216614/stem-cells-undo-birth-defects/ |website=MIT Technology Review |language=en}}</ref>) and presented in an invited major address, at the  international conferences in [[San Antonio, Texas]], in June 2016.<ref>{{Cite journal |last=Yanai |first=Joseph |date=May 2016 |title=Fortieth Anniversary Annual Meeting of the Developmental Neurotoxicology Society Held in Conjunction with the 56th Annual Meeting of the Teratology Society Grand Hyatt San Antonio, San Antonio, Texas June 25–29, 2016 |url=http://dx.doi.org/10.1016/j.ntt.2016.04.003 |journal=Neurotoxicology and Teratology |volume=55 |pages=58–75 |doi=10.1016/j.ntt.2016.04.003 |issn=0892-0362}}</ref> Review of Yanai’s work and the progress in reversal of neurobehavioral teratology that was advanced by other laboratories was published in 2019<ref>{{Cite journal |last1=Yanai |first1=Joseph |last2=Vigoda |first2=Myles J. |last3=Ornoy |first3=Asher |date=August 2019 |title=Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress |url=http://dx.doi.org/10.1016/j.brainresbull.2019.06.009 |journal=Brain Research Bulletin |volume=150 |pages=328–342 |doi=10.1016/j.brainresbull.2019.06.009 |pmid=31207281 |s2cid=189820103 |issn=0361-9230}}</ref> and in Basel, Switzerland in February 2017.
== Books ==
* Yanai, J. (Ed) Neurobehavioral Teratology. Elsevier, Amsterdam. (1984) {{ISBN|9780444805164}}<ref>{{cite journal |title=Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress |journal=Brain Research Bulletin |date=August 2019 |volume=150 |pages=328–342 |doi=10.1016/j.brainresbull.2019.06.009 |url=https://pubmed.ncbi.nlm.nih.gov/31207281/ |issn=1873-2747}}</ref>
* Yanai, J., R. Bauml, P. Eldar and J.M. Rosenfeld (Eds) Alcohol Dependence the Family and the Community. Freund, London. (1988)


== References ==
==References==
<!--- See http://en.wikipedia.org/wiki/Wikipedia:Footnotes on how to create references using<ref></ref> tags, these references will then appear here automatically -->
<!--- See http://en.wikipedia.org/wiki/Wikipedia:Footnotes on how to create references using<ref></ref> tags, these references will then appear here automatically -->
{{Reflist}}
{{Reflist}}
Line 39: Line 52:
[[Category:Israeli academics]]
[[Category:Israeli academics]]
[[Category:Israeli academic administrators]]
[[Category:Israeli academic administrators]]
[[Category:Hebrew University of Jerusalem faculty]]
[[Category:Academic staff of the Hebrew University of Jerusalem]]
[[Category:Israeli scientists]]
[[Category:Israeli scientists]]
[[Category:Israeli biologists]]
[[Category:Israeli biologists]]

Latest revision as of 12:25, 14 October 2024

Not to be confused with Joseph Yaani Labik.
Joseph Yanai
Born1944
Rehovot, Israel
NationalityIsraeli
Alma materHebrew University of Jerusalem, University of Colorado Boulder
Known forReversal of neurobehavioral birth defects in animal models
Notable workStudies on neurobehavioral teratology
TitleProfessor and Director of the Ross Laboratory for Studies in Neural Birth Defects
Scientific career
FieldsNeurobiology, Pharmacology
InstitutionsHebrew University of Jerusalem, Duke University School of Medicine

Joseph Yanai is a researcher pioneering in studying the reversal of neurobehavioral birth defects in animal models.[1] He serves as a professor and Director of the Ross Laboratory for Studies in Neural Birth Defects at the Department of Medical Neurobiology, The Institute For Medical Research, Israel-Canada (IMRIC) at the Hebrew University-Hadassah Medical School Jerusalem, Israel and was also appointed as adjunct professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, US.

Education

[edit]

Yanai was born in Rehovot, Israel in 1944. After graduating from the Mikveh Israel Agricultural High School, he received his BSc Agr. in agriculture and genetics at the Hebrew University of Jerusalem in 1967; both his MA in 1970 and PhD in 1971 from the University of Colorado Boulder

Professional career

[edit]

Research work

[edit]

Since 1973, he has been among the forerunners in the study of behavioral birth defects.[3] His novel approach was to study the mechanism by which certain neuroteratogens induce their deleterious effect, focusing on behavioral defects that are mechanistically related to septohippocampal cholinergic innervation.[4] The results showed alterations in cholinergic neurotransmission cascade converging into the abolishment of the cholinergic receptor-induced activation/translocation PKC activity.[5] By ascertaining the mechanisms of the neuroteratogenicity, he pointed in his book “neurobehavioral teratology.” [6] to the future of the field by establishing the concept of "Neurobehavioral teratology. Furthermore, Yanai argued that understanding the mechanism of the developmental defect will eventually enable its reversal, a concept that seemed like science fiction in 1984.

Specifically since 1987, Yanai has developed animal models for the reversal of neurobehavioral birth defects, starting with manipulation of A10 septal dopaminergic innervation,[7] nicotine therapy,[8] but most significantly, by transplantation of cells to the impaired brain. These included fetal differentiated brain cells (neural grafting),[9] and in subsequent studies, stem cells of various origins: embryonic, neural stem cells,[10] subventricular stem cells,[11] and mesenchymal stem cells.[12][13] Transplantation of cells of all types reversed the prenatally-induced behavioral deficits and the mechanistically related neural alterations. Further studies suggested that one major mechanism by which the stem cells exert their therapeutic action is by enhancing neurogenesis.[14][15]

These findings were published in the leading journal (for example Molecular Psychiatry,[16]) and received a widespread media attention (external links[17][18]) and presented in an invited major address, at the  international conferences in San Antonio, Texas, in June 2016.[19] Review of Yanai’s work and the progress in reversal of neurobehavioral teratology that was advanced by other laboratories was published in 2019[20] and in Basel, Switzerland in February 2017.

References

[edit]
  1. ^ Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN 0361-9230. PMID 31207281. S2CID 189820103.
  2. ^ "Professor Joseph Yanai". The Hebrew University of Jerusalem.
  3. ^ "Behavior genetics association abstracts". Behavior Genetics. 3 (4): 393–419. December 1973. doi:10.1007/bf01070223. ISSN 0001-8244. S2CID 189854750.
  4. ^ "Behavior genetics association abstracts". Behavior Genetics. 3 (4): 393–419. December 1973. doi:10.1007/bf01070223. ISSN 0001-8244. S2CID 189854750.
  5. ^ Yanai, Joseph; Beer, Avital; Huleihel, Rabab; Izrael, Michal; Katz, Sofia; Levi, Yaarit; Rozenboim, Israel; Yaniv, Shiri P.; Slotkin, Theodore A. (October 2004). "Convergent Effects on Cell Signaling Mechanisms Mediate the Actions of Different Neurobehavioral Teratogens: Alterations in Cholinergic Regulation of Protein Kinase C in Chick and Avian Models". Annals of the New York Academy of Sciences. 1025 (1): 595–601. doi:10.1196/annals.1316.074. ISSN 0077-8923. PMID 15542768. S2CID 10927050.
  6. ^ Joseph Yanai, ed. (1984). Neurobehavioral teratology. Amsterdam: Elsevier. ISBN 0-444-80516-8. OCLC 10275574.
  7. ^ Yanai, Joseph; Laxer, Uri; Pick, Chaim G.; Trombka, David (August 1989). "Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital". Developmental Brain Research. 48 (2): 255–261. doi:10.1016/0165-3806(89)90080-1. ISSN 0165-3806. PMID 2505945.
  8. ^ Beer, Avital; Slotkin, Theodore A; Seidler, Frederic J; Aldridge, Justin E; Yanai, Joseph (2004-10-20). "Nicotine Therapy in Adulthood Reverses the Synaptic and Behavioral Deficits Elicited by Prenatal Exposure to Phenobarbital". Neuropsychopharmacology. 30 (1): 156–165. doi:10.1038/sj.npp.1300582. ISSN 0893-133X. PMID 15496940.
  9. ^ Yanai, Joseph; Pick, Chaim G. (1988). "Neuron transplantation reverses phenobarbital-induced behavioral birth defects in mice". International Journal of Developmental Neuroscience. 6 (5): 409–416. doi:10.1016/0736-5748(88)90046-9. ISSN 0736-5748. PMID 3202000. S2CID 23370083.
  10. ^ Kazma, Meital; Izrael, Michal; Revel, Michel; Chebath, Judith; Yanai, Joseph (2010-02-01). "Survival, differentiation, and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural stem cells derived from embryonic stem cells". Journal of Neuroscience Research. 88 (2): 315–323. doi:10.1002/jnr.22193. ISSN 0360-4012. PMID 19746435. S2CID 24682086.
  11. ^ Turgeman, Gadi; Pinkas, Adi; Slotkin, Theodore A.; Tfilin, Matanel; Langford, Rachel; Yanai, Joseph (2011-04-21). "Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by allographic transplantation of adult subventricular zone-derived neural stem cells". Journal of Neuroscience Research. 89 (8): 1185–1193. doi:10.1002/jnr.22631. ISSN 0360-4012. PMID 21520219. S2CID 3424029.
  12. ^ Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN 0361-9230. PMID 31207281. S2CID 189820103.
  13. ^ "Stem cell therapy may reverse brain birth defects". Oneindia.com. 30 December 2008.
  14. ^ "Health Scan: Stem cell therapy may reverse brain defects". The Jerusalem Post.
  15. ^ Ben-Shaanan, T L; Ben-Hur, T; Yanai, J (2007-09-18). "Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain". Molecular Psychiatry. 13 (2): 222–231. doi:10.1038/sj.mp.4002084. ISSN 1359-4184. PMID 17876325. S2CID 12784221.
  16. ^ Ben-Shaanan, TL, Ben-Hur, T, and Yanai, J.: “Transplantation of neural progenitors enhances production of endogeneous cells in the impaired brain”. Molecular Psychiatry, September 18, 2007. Vol. 13, No. 2, pp222-231
  17. ^ "Hebrew University Scientists Succeed Through Stem Cell Therapy in Reversing Brain Birth Defects". Technology Networks.
  18. ^ "Stem Cells Undo Birth Defects". MIT Technology Review.
  19. ^ Yanai, Joseph (May 2016). "Fortieth Anniversary Annual Meeting of the Developmental Neurotoxicology Society Held in Conjunction with the 56th Annual Meeting of the Teratology Society Grand Hyatt San Antonio, San Antonio, Texas June 25–29, 2016". Neurotoxicology and Teratology. 55: 58–75. doi:10.1016/j.ntt.2016.04.003. ISSN 0892-0362.
  20. ^ Yanai, Joseph; Vigoda, Myles J.; Ornoy, Asher (August 2019). "Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress". Brain Research Bulletin. 150: 328–342. doi:10.1016/j.brainresbull.2019.06.009. ISSN 0361-9230. PMID 31207281. S2CID 189820103.
[edit]
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Joseph_Yanai&oldid=1251103477"